{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T20:08:56Z","timestamp":1782936536961,"version":"3.54.5"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"FWO-TBM","award":["T001121N"],"award-info":[{"award-number":["T001121N"]}]},{"name":"FWO-TBM","award":["T001121N"],"award-info":[{"award-number":["T001121N"]}]},{"name":"FWO-TBM","award":["T001121N"],"award-info":[{"award-number":["T001121N"]}]},{"name":"FWO-TBM","award":["T001121N"],"award-info":[{"award-number":["T001121N"]}]},{"name":"Novartis Belgium"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The brainstem is a vital component of the cerebro-cerebellar network underlying cognition, however it remains unclear whether brainstem volumes are associated with cognitive functioning in MS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Investigate the relationship between brainstem volumes and cognitive impairment in MS, as assessed by the BICAMS battery (processing speed, verbal and visuospatial memory).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed data from the VOLUMS (Volumetry in MS) study, including 143 MS patients. Magnetic resonance imaging (1.5\/3.0\u00a0T, 3DT1-weighted images) was used for brain volumetrics and brainstem lesion counts. Cognitive data were collected using the \u201cBrief International Assessment of Cognition for Multiple Sclerosis\u201d (BICAMS). Correlation and stepwise logistic regression explored associations between brain volumes and cognitive performance. In a subset of 35 patients with 3-year follow-up, longitudinal changes in brain volumes and cognition were also assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Cognitive impairment (\u2265\u20092 standard deviations below predicted scores on at least one test) was present in 30.1% of participants. No significant correlations were found between brainstem volume and cognitive scores. Hippocampus (p\u2009=\u2009.046), thalamus (p\u2009=\u2009.024), cortex (p\u2009&lt;\u2009.001), and gray matter (p\u2009&lt;\u2009.001) volumes were significantly lower in cognitively impaired patients. Processing speed correlated with cortex (R\u2009=\u2009.217, p\u2009=\u2009.009) and GM (R\u2009=\u2009.206, p\u2009=\u2009.013), while verbal memory correlated with hippocampus (R\u2009=\u2009.218, p\u2009=\u2009.009), cortex (R\u2009=\u2009.251, p\u2009=\u2009.003) and GM (R\u2009=\u2009.275, p\u2009=\u2009.001) volumes. Disease duration was the only significant predictor of cognitive impairment (p\u2009&lt;\u2009.001). In the longitudinal subset, no clear evidence of progressive volumetric decline or related cognitive deterioration was observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>While no link was found between brainstem volumes and cognitive impairment, this analysis underscores the importance of considering various brain structures in understanding cognitive impairment in MS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s13760-025-02928-3","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:19:11Z","timestamp":1762147151000},"page":"197-206","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cognitive functioning in multiple sclerosis with focus on brainstem volume"],"prefix":"10.1007","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7454-0026","authenticated-orcid":false,"given":"Eline","family":"Van Doninck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Victoria","family":"De Keersmaecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"D\u2019hooghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Van Wijmeersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Perrotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souraya","family":"El Sankari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"van Pesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Dive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"D\u2019Haeseleer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Laureys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Willekens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lander","family":"Willem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Belgian Study Group Multiple Sclerosis (BSGMS)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"issue":"10422","key":"2928_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0140-6736(23)01473-3","volume":"403","author":"D Jakimovski","year":"2024","unstructured":"Jakimovski D, Bittner S, Zivadinov R, Morrow SA, Benedict RH, Zipp F et al (2024) Multiple sclerosis. Lancet 403(10422):183\u2013202","journal-title":"Lancet"},{"issue":"1","key":"2928_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","volume":"26","author":"R Dobson","year":"2019","unstructured":"Dobson R, Giovannoni G (2019) Multiple sclerosis-a review. Eur J Neurol 26(1):27\u201340","journal-title":"Eur J Neurol"},{"issue":"10","key":"2928_CR3","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/S1474-4422(20)30277-5","volume":"19","author":"RHB Benedict","year":"2020","unstructured":"Benedict RHB, Amato MP, DeLuca J, Geurts JJG (2020) Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues. Lancet Neurol 19(10):860\u2013871","journal-title":"Lancet Neurol"},{"issue":"1","key":"2928_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/bpa.12220","volume":"25","author":"GC DeLuca","year":"2015","unstructured":"DeLuca GC, Yates RL, Beale H, Morrow SA (2015) Cognitive impairment in multiple sclerosis: clinical, radiologic and pathologic insights. Brain Pathol 25(1):79\u201398","journal-title":"Brain Pathol"},{"issue":"6","key":"2928_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41582-020-0355-1","volume":"16","author":"J DeLuca","year":"2020","unstructured":"DeLuca J, Chiaravalloti ND, Sandroff BM (2020) Treatment and management of cognitive dysfunction in patients with multiple sclerosis. Nat Rev Neurol 16(6):319\u2013332","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"2928_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13317-019-0117-5","volume":"10","author":"A Andravizou","year":"2019","unstructured":"Andravizou A, Dardiotis E, Artemiadis A, Sokratous M, Siokas V, Tsouris Z et al (2019) Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options. Auto Immun Highlights 10(1):7","journal-title":"Auto Immun Highlights"},{"issue":"5","key":"2928_CR7","doi-asserted-by":"publisher","first-page":"e37049","DOI":"10.1371\/journal.pone.0037049","volume":"7","author":"N Shiee","year":"2012","unstructured":"Shiee N, Bazin PL, Zackowski KM, Farrell SK, Harrison DM, Newsome SD et al (2012) Revisiting brain atrophy and its relationship to disability in multiple sclerosis. PLoS ONE 7(5):e37049","journal-title":"PLoS ONE"},{"issue":"3","key":"2928_CR8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/ana.21436","volume":"64","author":"E Fisher","year":"2008","unstructured":"Fisher E, Lee JC, Nakamura K, Rudick RA (2008) Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol 64(3):255\u2013265","journal-title":"Ann Neurol"},{"issue":"Pt 10","key":"2928_CR9","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1093\/brain\/aws246","volume":"135","author":"M Calabrese","year":"2012","unstructured":"Calabrese M, Poretto V, Favaretto A, Alessio S, Bernardi V, Romualdi C et al (2012) Cortical lesion load associates with progression of disability in multiple sclerosis. Brain 135(Pt 10):2952\u20132961","journal-title":"Brain"},{"issue":"9","key":"2928_CR10","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1001\/archneurol.2009.174","volume":"66","author":"M Calabrese","year":"2009","unstructured":"Calabrese M, Agosta F, Rinaldi F, Mattisi I, Grossi P, Favaretto A et al (2009) Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 66(9):1144\u20131150","journal-title":"Arch Neurol"},{"issue":"9","key":"2928_CR11","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1177\/1352458511404916","volume":"17","author":"SD Roosendaal","year":"2011","unstructured":"Roosendaal SD, Bendfeldt K, Vrenken H, Polman CH, Borgwardt S, Radue EW et al (2011) Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability. Mult Scler 17(9):1098\u20131106","journal-title":"Mult Scler"},{"key":"2928_CR12","first-page":"609694","volume":"2014","author":"S Messina","year":"2014","unstructured":"Messina S, Patti F (2014) Gray matters in multiple sclerosis: cognitive impairment and structural MRI. Mult Scler Int 2014:609694","journal-title":"Mult Scler Int"},{"issue":"3","key":"2928_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/00019052-200206000-00003","volume":"15","author":"F Barkhof","year":"2002","unstructured":"Barkhof F (2002) The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 15(3):239\u2013245","journal-title":"Curr Opin Neurol"},{"key":"2928_CR14","doi-asserted-by":"publisher","first-page":"105017","DOI":"10.1016\/j.msard.2023.105017","volume":"79","author":"C Stein","year":"2023","unstructured":"Stein C, O\u2019Keeffe F, Strahan O, McGuigan C, Bramham J (2023) Systematic review of cognitive reserve in multiple sclerosis: Accounting for physical disability, fatigue, depression, and anxiety. Mult Scler Relat Disord 79:105017","journal-title":"Mult Scler Relat Disord"},{"key":"2928_CR15","doi-asserted-by":"publisher","first-page":"307175","DOI":"10.1155\/2015\/307175","volume":"2015","author":"DJ Ksiazek-Winiarek","year":"2015","unstructured":"Ksiazek-Winiarek DJ, Szpakowski P, Glabinski A (2015) Neural plasticity in multiple sclerosis: the functional and molecular background. Neural Plast 2015:307175","journal-title":"Neural Plast"},{"key":"2928_CR16","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.11932.1","volume":"6","author":"D Chard","year":"2017","unstructured":"Chard D, Trip SA (2017) Resolving the clinico-radiological paradox in multiple sclerosis. F1000Res 6:1828","journal-title":"F1000Res"},{"issue":"1","key":"2928_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41467-022-35658-8","volume":"14","author":"E Boven","year":"2023","unstructured":"Boven E, Pemberton J, Chadderton P, Apps R, Costa RP (2023) Cerebro-cerebellar networks facilitate learning through feedback decoupling. Nat Commun 14(1):51","journal-title":"Nat Commun"},{"issue":"10","key":"2928_CR18","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41583-018-0053-9","volume":"19","author":"M Di Filippo","year":"2018","unstructured":"Di Filippo M, Portaccio E, Mancini A, Calabresi P (2018) Multiple sclerosis and cognition: synaptic failure and network dysfunction. Nat Rev Neurosci 19(10):599\u2013609","journal-title":"Nat Rev Neurosci"},{"key":"2928_CR19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3389\/fnins.2018.00395","volume":"12","author":"H Nishijo","year":"2018","unstructured":"Nishijo H, Rafal R, Tamietto M (2018) Editorial: limbic-brainstem roles in perception, cognition, emotion, and behavior. Front Neurosci 12:395","journal-title":"Front Neurosci"},{"issue":"1\u20132","key":"2928_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jns.2008.12.034","volume":"282","author":"DP Ramasamy","year":"2009","unstructured":"Ramasamy DP, Benedict RH, Cox JL, Fritz D, Abdelrahman N, Hussein S et al (2009) Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study. J Neurol Sci 282(1\u20132):47\u201354","journal-title":"J Neurol Sci"},{"issue":"12","key":"2928_CR21","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1212\/01.wnl.0000276992.17011.b5","volume":"69","author":"MK Houtchens","year":"2007","unstructured":"Houtchens MK, Benedict RH, Killiany R, Sharma J, Jaisani Z, Singh B et al (2007) Thalamic atrophy and cognition in multiple sclerosis. Neurology 69(12):1213\u20131223","journal-title":"Neurology"},{"key":"2928_CR22","doi-asserted-by":"publisher","first-page":"102351","DOI":"10.1016\/j.msard.2020.102351","volume":"45","author":"L Lorefice","year":"2020","unstructured":"Lorefice L, Carta E, Frau J, Contu F, Casaglia E, Coghe G et al (2020) The impact of deep grey matter volume on cognition in multiple sclerosis. Mult Scler Relat Disord 45:102351","journal-title":"Mult Scler Relat Disord"},{"issue":"17","key":"2928_CR23","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1212\/WNL.0b013e3182703f46","volume":"79","author":"MM Schoonheim","year":"2012","unstructured":"Schoonheim MM, Popescu V, Rueda Lopes FC, Wiebenga OT, Vrenken H, Douw L et al (2012) Subcortical atrophy and cognition: sex effects in multiple sclerosis. Neurology 79(17):1754\u20131761","journal-title":"Neurology"},{"issue":"1","key":"2928_CR24","doi-asserted-by":"publisher","first-page":"e86916","DOI":"10.1371\/journal.pone.0086916","volume":"9","author":"K Weier","year":"2014","unstructured":"Weier K, Penner IK, Magon S, Amann M, Naegelin Y, Andelova M et al (2014) Cerebellar abnormalities contribute to disability including cognitive impairment in multiple sclerosis. PLoS ONE 9(1):e86916","journal-title":"PLoS ONE"},{"key":"2928_CR25","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1146\/annurev-neuro-070918-050258","volume":"42","author":"JD Schmahmann","year":"2019","unstructured":"Schmahmann JD, Guell X, Stoodley CJ, Halko MA (2019) The theory and neuroscience of cerebellar cognition. Annu Rev Neurosci 42:337\u2013364","journal-title":"Annu Rev Neurosci"},{"issue":"3","key":"2928_CR26","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1586\/ern.13.18","volume":"13","author":"M Habek","year":"2013","unstructured":"Habek M (2013) Evaluation of brainstem involvement in multiple sclerosis. Expert Rev Neurother 13(3):299\u2013311","journal-title":"Expert Rev Neurother"},{"issue":"6","key":"2928_CR27","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/jmri.25866","volume":"47","author":"CY Lee","year":"2018","unstructured":"Lee CY, Mak HK, Chiu PW, Chang HC, Barkhof F, Chan KH (2018) Differential brainstem atrophy patterns in multiple sclerosis and neuromyelitis optica spectrum disorders. J Magn Reson Imaging 47(6):1601\u20131609","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"2928_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1136\/jnnp.73.2.191","volume":"73","author":"P Garrard","year":"2002","unstructured":"Garrard P, Bradshaw D, Jager HR, Thompson AJ, Losseff N, Playford D (2002) Cognitive dysfunction after isolated brain stem insult. An underdiagnosed cause of long term morbidity. J Neurol Neurosurg Psychiatry 73(2):191\u20134","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"2928_CR29","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s12311-014-0626-8","volume":"14","author":"T D'Aes","year":"2015","unstructured":"D\u2019Aes T, Marien P (2015) Cognitive and affective disturbances following focal brainstem lesions: a review and report of three cases. Cerebellum 14(3):317\u2013340","journal-title":"Cerebellum"},{"issue":"2","key":"2928_CR30","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292\u2013302","journal-title":"Ann Neurol"},{"key":"2928_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1471-2377-12-55","volume":"12","author":"RH Benedict","year":"2012","unstructured":"Benedict RH, Amato MP, Boringa J, Brochet B, Foley F, Fredrikson S et al (2012) Brief International Cognitive Assessment for MS (BICAMS): international standards for validation. BMC Neurol 12:55","journal-title":"BMC Neurol"},{"issue":"6","key":"2928_CR32","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1177\/1352458511431076","volume":"18","author":"DW Langdon","year":"2012","unstructured":"Langdon DW, Amato MP, Boringa J, Brochet B, Foley F, Fredrikson S (2012) Recommendations for a brief international cognitive assessment for multiple sclerosis (BICAMS). Mult Scler 18(6):891\u2013898","journal-title":"Mult Scler"},{"key":"2928_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12020703","author":"H Potticary","year":"2023","unstructured":"Potticary H, Langdon D (2023) A systematic review and meta-analysis of the Brief Cognitive Assessment for Multiple Sclerosis (BICAMS) International validations. J Clin Med. https:\/\/doi.org\/10.3390\/jcm12020703","journal-title":"J Clin Med"},{"key":"2928_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.msard.2017.08.018","volume":"18","author":"L Costers","year":"2017","unstructured":"Costers L, Gielen J, Eelen PL, Schependom JV, Laton J, Remoortel AV et al (2017) Does including the full CVLT-II and BVMT-R improve BICAMS? Evidence from a Belgian (Dutch) validation study. Mult Scler Relat Disord 18:33\u201340","journal-title":"Mult Scler Relat Disord"},{"key":"2928_CR35","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jns.2017.08.019","volume":"381","author":"M Beier","year":"2017","unstructured":"Beier M, Gromisch ES, Hughes AJ, Alschuler KN, Madathil R, Chiaravalloti N et al (2017) Proposed cut scores for tests of the Brief International Cognitive Assessment of Multiple Sclerosis (BICAMS). J Neurol Sci 381:110\u2013116","journal-title":"J Neurol Sci"},{"issue":"2","key":"2928_CR36","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.neuroimage.2012.01.021","volume":"62","author":"B Fischl","year":"2012","unstructured":"Fischl B (2012) FreeSurfer Neuroimage 62(2):774\u2013781","journal-title":"FreeSurfer Neuroimage"},{"issue":"4","key":"2928_CR37","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1016\/j.neuroimage.2012.02.084","volume":"61","author":"M Reuter","year":"2012","unstructured":"Reuter M, Schmansky NJ, Rosas HD, Fischl B (2012) Within-subject template estimation for unbiased longitudinal image analysis. Neuroimage 61(4):1402\u20131418","journal-title":"Neuroimage"},{"key":"2928_CR38","unstructured":"Evans JD. Straightforward statistics for the behavioral sciences.: Thomson Brooks\/Cole Publishing Co. 1996."},{"issue":"13","key":"2928_CR39","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1177\/1352458518808204","volume":"25","author":"L Strober","year":"2019","unstructured":"Strober L, DeLuca J, Benedict RH, Jacobs A, Cohen JA, Chiaravalloti N (2019) Symbol digit modalities test: a valid clinical trial endpoint for measuring cognition in multiple sclerosis. Mult Scler 25(13):1781\u20131790","journal-title":"Mult Scler"},{"issue":"2","key":"2928_CR40","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1136\/jnnp.2008.148403","volume":"80","author":"RH Benedict","year":"2009","unstructured":"Benedict RH, Ramasamy D, Munschauer F, Weinstock-Guttman B, Zivadinov R (2009) Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy. J Neurol Neurosurg Psychiatry 80(2):201\u2013206","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2928_CR41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jns.2018.01.011","volume":"386","author":"G Fenu","year":"2018","unstructured":"Fenu G, Lorefice L, Arru M, Sechi V, Loi L, Contu F et al (2018) Cognition in multiple sclerosis: Between cognitive reserve and brain volume. J Neurol Sci 386:19\u201322","journal-title":"J Neurol Sci"},{"issue":"1","key":"2928_CR42","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12883-018-1065-9","volume":"18","author":"J Frau","year":"2018","unstructured":"Frau J, Fenu G, Signori A, Coghe G, Lorefice L, Barracciu MA et al (2018) A cross-sectional and longitudinal study evaluating brain volumes, RNFL, and cognitive functions in MS patients and healthy controls. BMC Neurol 18(1):67","journal-title":"BMC Neurol"},{"issue":"1","key":"2928_CR43","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00415-011-6147-1","volume":"259","author":"S Batista","year":"2012","unstructured":"Batista S, Zivadinov R, Hoogs M, Bergsland N, Heininen-Brown M, Dwyer MG et al (2012) Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis. J Neurol 259(1):139\u2013146","journal-title":"J Neurol"},{"issue":"10","key":"2928_CR44","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1177\/1352458515616204","volume":"22","author":"N Bergsland","year":"2016","unstructured":"Bergsland N, Zivadinov R, Dwyer MG, Weinstock-Guttman B, Benedict RH (2016) Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients. Mult Scler 22(10):1327\u20131336","journal-title":"Mult Scler"},{"issue":"3","key":"2928_CR45","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1177\/1352458519826364","volume":"26","author":"ES Sotirchos","year":"2020","unstructured":"Sotirchos ES, Gonzalez-Caldito N, Dewey BE, Fitzgerald KC, Glaister J, Filippatou A (2020) Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis. Mult Scler 26(3):312\u2013321","journal-title":"Mult Scler"},{"key":"2928_CR46","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.3389\/fneur.2018.01172","volume":"9","author":"E Toth","year":"2018","unstructured":"Toth E, Farago P, Kiraly A, Szabo N, Vereb D, Kocsis K et al (2018) The Contribution of Various MRI Parameters to Clinical and Cognitive Disability in Multiple Sclerosis. Front Neurol 9:1172","journal-title":"Front Neurol"},{"issue":"4","key":"2928_CR47","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1177\/1352458518760716","volume":"25","author":"KA Koenig","year":"2019","unstructured":"Koenig KA, Rao SM, Lowe MJ, Lin J, Sakaie KE, Stone L et al (2019) The role of the thalamus and hippocampus in episodic memory performance in patients with multiple sclerosis. Mult Scler 25(4):574\u2013584","journal-title":"Mult Scler"},{"key":"2928_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2015.00082","volume":"6","author":"MM Schoonheim","year":"2015","unstructured":"Schoonheim MM, Meijer KA, Geurts JJ (2015) Network collapse and cognitive impairment in multiple sclerosis. Front Neurol 6:82","journal-title":"Front Neurol"},{"key":"2928_CR49","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jns.2018.03.003","volume":"388","author":"R Manca","year":"2018","unstructured":"Manca R, Sharrack B, Paling D, Wilkinson ID, Venneri A (2018) Brain connectivity and cognitive processing speed in multiple sclerosis: A systematic review. J Neurol Sci 388:115\u2013127","journal-title":"J Neurol Sci"},{"issue":"9","key":"2928_CR50","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1177\/1352458516674367","volume":"23","author":"L Ruano","year":"2017","unstructured":"Ruano L, Portaccio E, Goretti B, Niccolai C, Severo M, Patti F et al (2017) Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes. Mult Scler 23(9):1258\u20131267","journal-title":"Mult Scler"},{"key":"2928_CR51","doi-asserted-by":"publisher","first-page":"102972","DOI":"10.1016\/j.nicl.2022.102972","volume":"34","author":"N De Stefano","year":"2022","unstructured":"De Stefano N, Battaglini M, Pareto D, Cortese R, Zhang J, Oesingmann N et al (2022) MAGNIMS recommendations for harmonization of MRI data in MS multicenter studies. Neuroimage Clin 34:102972","journal-title":"Neuroimage Clin"},{"key":"2928_CR52","doi-asserted-by":"publisher","first-page":"104375","DOI":"10.1016\/j.msard.2022.104375","volume":"68","author":"TA Fuchs","year":"2022","unstructured":"Fuchs TA, Gillies J, Jaworski MG 3rd, Wilding GE, Youngs M, Weinstock-Guttman B et al (2022) Repeated forms, testing intervals, and SDMT performance in a large multiple sclerosis dataset. Mult Scler Relat Disord 68:104375","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"2928_CR53","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcac153","volume":"4","author":"T Brummer","year":"2022","unstructured":"Brummer T, Muthuraman M, Steffen F, Uphaus T, Minch L, Person M et al (2022) Improved prediction of early cognitive impairment in multiple sclerosis combining blood and imaging biomarkers. Brain Commun 4(4):fcac153","journal-title":"Brain Commun"},{"issue":"8","key":"2928_CR54","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1007\/s00415-023-11676-4","volume":"270","author":"M van Dam","year":"2023","unstructured":"van Dam M, de Jong BA, Willemse EAJ, Nauta IM, Huiskamp M, Klein M et al (2023) A multimodal marker for cognitive functioning in multiple sclerosis: the role of NfL, GFAP and conventional MRI in predicting cognitive functioning in a prospective clinical cohort. J Neurol 270(8):3851\u20133861","journal-title":"J Neurol"},{"key":"2928_CR55","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3389\/fnins.2017.00380","volume":"11","author":"J Van Schependom","year":"2017","unstructured":"Van Schependom J, Nagels G (2017) Targeting cognitive impairment in multiple sclerosis-the road toward an imaging-based biomarker. Front Neurosci 11:380","journal-title":"Front Neurosci"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-025-02928-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-025-02928-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-025-02928-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T08:02:43Z","timestamp":1773388963000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-025-02928-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2928"],"URL":"https:\/\/doi.org\/10.1007\/s13760-025-02928-3","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AD received conference travel support from Biogen and research funding from Belgian Charcot Foundation. BV has received speaker\/advisor fees, research support and travel grants: Almirall, Actelion\/Janssen, Bayer, Biogen, Celgene\/BMS, Imcyse, Merck, Novartis, Roche and Sanofi Genzyme. VV has received travel grants from Merck Healthcare KGaA (Darmstadt, Germany), Biogen, Sanofi, Bristol Meyer Squibb, Almirall and Roche. His institution has received research grants and consultancy fees from Roche, Biogen, Sanofi, Merck Healthcare KGaA (Darmstadt, Germany), Bristol Meyer Squibb, Janssen, Almirall, Alexion and Novartis Pharma. BW received honoraria for acting as a member of Scientific Advisory Boards\/Consultancy for Almirall, Biogen, Celgene\/BMS, Merck, Janssen, Novartis, Roche, Sandoz, Sanofi-Genzyme and speaker honoraria and travel support from Biogen, Celgene\/BMS, Merck, Novartis, Roche, SanofiGenzyme; research and\/or patient support grants from Biogen, Janssen, Merck, Sanofi-Genzyme, Roche. Honoraria and grants were paid to UZA\/UZA Foundation. Further, BW received research funding from FWO-TBM, Belgian Charcot Foundation, Start2Cure Foundation, Queen Elisabeth Medical Foundation for Neurosciences and the National MS Society USA. VP has received honoraria and travel and research grants from Almirall, Biogen, Medtronic, Merck, Novartis, Roche, Sanofi-Genzyme and Teva Pharmaceuticals. EV, MDh, MDH, GP, SES, DD, GL and LW have nothing to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}